|
1
|
Siegel RL, Miller KD, Wagle NS and Jemal
A: Cancer statistics, 2023. CA Cancer J Clin. 73:17–48. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Wagle NS, Cercek A, Smith RA
and Jemal A: Colorectal cancer statistics, 2023. CA Cancer J Clin.
73:233–254. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brenner H, Heisser T, Cardoso R and
Hoffmeister M: Reduction in colorectal cancer incidence by
screening endoscopy. Nat Rev Gastroenterol Hepatol. 21:125–133.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bhupender S and Chhikara KP: Global Cancer
Statistics 2022: The trends projection analysis. Chem Biol Lett.
10:4512023.
|
|
5
|
Biller LH and Schrag D: Diagnosis and
treatment of metastatic colorectal cancer: A review. JAMA.
325:669–685. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Malki A, ElRuz RA, Gupta I, Allouch A,
Vranic S and Al Moustafa AE: Molecular mechanisms of colon cancer
progression and metastasis: Recent insights and advancements. Int J
Mol Sci. 22:1302020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vogelstein B, Fearon ER, Hamilton SR, Kern
SE, Preisinger AC, Leppert M, Smits AM and Bos JL: Genetic
alterations during colorectal-tumor development. N Engl J Med.
319:525–532. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wilson BG and Roberts CWM: SWI/SNF
nucleosome remodellers and cancer. Nat Rev Cancer. 11:481–492.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reisman D, Glaros S and Thompson E: The
SWI/SNF complex and cancer. Oncogene. 28:1653–1668. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shain AH and Pollack JR: The spectrum of
SWI/SNF mutations, ubiquitous in human cancers. PLoS One.
8:e551192013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wiegand KC, Shah SP, Al-Agha OM, Zhao Y,
Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, et
al: ARID1A mutations in endometriosis-associated ovarian
carcinomas. N Engl J Med. 363:1532–1543. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mamo A, Cavallone L, Tuzmen S, Chabot C,
Ferrario C, Hassan S, Edgren H, Kallioniemi O, Aleynikova O,
Przybytkowski E, et al: An integrated genomic approach identifies
ARID1A as a candidate tumor-suppressor gene in breast cancer.
Oncogene. 31:2090–2100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guichard C, Amaddeo G, Imbeaud S, Ladeiro
Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M,
Degos F, et al: Integrated analysis of somatic mutations and focal
copy-number changes identifies key genes and pathways in
hepatocellular carcinoma. Nat Genet. 44:694–698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Streppel MM, Lata S, DelaBastide M,
Montgomery EA, Wang JS, Canto MI, Macgregor-Das AM, Pai S, Morsink
FH, Offerhaus GJ, et al: Next-generation sequencing of endoscopic
biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's
esophagus. Oncogene. 33:347–357. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Muzny DM, Bainbridge MN, Chang K, Dinh HH,
Drummond JA, Fowler G, Kovar CL, Lewis LR, Morgan MB, Newsham IF,
et al: Comprehensive molecular characterization of human colon and
rectal cancer. Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei XL, Wang DS, Xi SY, Wu WJ, Chen DL,
Zeng ZL, Wang RY, Huang YX, Jin Y, Wang F, et al: Clinicopathologic
and prognostic relevance of ARID1A protein loss in colorectal
cancer. World J Gastroenterol. 20:18404–18412. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ye J, Zhou Y, Weiser MR, Gönen M, Zhang L,
Samdani T, Bacares R, DeLair D, Ivelja S, Vakiani E, et al:
Immunohistochemical detection of ARID1A in colorectal carcinoma:
Loss of staining is associated with sporadic microsatellite
unstable tumors with medullary histology and high TNM stage. Hum
Pathol. 45:2430–2436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Toiyama Y, Yasuda H, Saigusa S, Tanaka K,
Inoue Y, Goel A and Kusunoki M: Increased expression of Slug and
Vimentin as novel predictive biomarkers for lymph node metastasis
and poor prognosis in colorectal cancer. Carcinogenesis.
34:2548–2557. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ye X and Weinberg RA:
Epithelial-Mesenchymal plasticity: A central regulator of cancer
progression. Trends Cell Biol. 25:675–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brabletz T, Kalluri R, Nieto MA and
Weinberg RA: EMT in cancer. Nat Rev Cancer. 18:128–134. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gurzu S, Silveanu C, Fetyko A, Butiurca V,
Kovacs Z and Jung I: Systematic review of the old and new concepts
in the epithelial-mesenchymal transition of colorectal cancer.
World J Gastroenterol. 22:6764–6775. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang T, Gao X, Zhou K, Jiang T, Gao S, Liu
P, Zuo X and Shi X: Role of ARID1A in epithelial-mesenchymal
transition in breast cancer and its effect on cell sensitivity to
5-FU. Int J Mol Med. 46:1683–1694. 2020.PubMed/NCBI
|
|
23
|
Yan HB, Wang XF, Zhang Q, Tang ZQ, Jiang
YH, Fan HZ, Sun YH, Yang PY and Liu F: Reduced expression of the
chromatin remodeling gene ARID1A enhances gastric cancer cell
migration and invasion via downregulation of E-cadherin
transcription. Carcinogenesis. 35:867–876. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tian X, Wei Z, Wang J, Liu P, Qin Y and
Zhong M: MicroRNA-429 inhibits the migration and invasion of colon
cancer cells by targeting PAK6/cofilin signaling. Oncol Rep.
34:707–714. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang R, Yang S, Wang M, Zhou Y, Li X, Chen
W, Liu W, Huang Y, Wu J and Cao J: A sustainable approach to
universal metabolic cancer diagnosis. Nat Sustainability.
7:602–615. 2024. View Article : Google Scholar
|
|
29
|
Graham TR, Zhau HE, Odero-Marah VA,
Osunkoya AO, Kimbro KS, Tighiouart M, Liu T, Simons JW and O'Regan
RM: Insulin-like growth factor-I-dependent up-regulation of ZEB1
drives epithelial-to-mesenchymal transition in human prostate
cancer cells. Cancer Res. 68:2479–2488. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leggett SE, Hruska AM, Guo M and Wong IY:
The epithelial-mesenchymal transition and the cytoskeleton in
bioengineered systems. Cell Commun Signal. 19:322021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Niknami Z, Eslamifar A, Emamirazavi A,
Ebrahimi A and Shirkoohi R: The association of vimentin and
fibronectin gene expression with epithelial-mesenchymal transition
and tumor malignancy in colorectal carcinoma. EXCLI J.
16:1009–1017. 2017.PubMed/NCBI
|
|
32
|
Zhao H, Ming T, Tang S, Ren S, Yang H, Liu
M, Tao Q and Xu H: Wnt signaling in colorectal cancer: Pathogenic
role and therapeutic target. Mol Cancer. 21:1442022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang Q, Huang W, Hsu JC, Song L, Sun X, Li
C, Cai W and Kang L: CD146-targeted nuclear medicine imaging in
cancer: State of the art. View (Beijing). 4:202200852023.PubMed/NCBI
|
|
34
|
Baldi S, Zhang Q, Zhang Z, Safi M, Khamgan
H, Wu H, Zhang M, Qian Y, Gao Y, Shopit A, et al: ARID1A
downregulation promotes cell proliferation and migration of colon
cancer via VIM activation and CDH1 suppression. Cell Mol Med.
26:5984–5997. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Erfani M, Hosseini SV, Mokhtari M, Zamani
M, Tahmasebi K, Alizadeh Naini M, Taghavi A, Carethers JM, Koi M,
Brim H, et al: Altered ARID1A expression in colorectal cancer. BMC
Cancer. 20:3502020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chou A, Toon CW, Clarkson A, Sioson L,
Houang M, Watson N, DeSilva K and Gill AJ: Loss of ARID1A
expression in colorectal carcinoma is strongly associated with
mismatch repair deficiency. Hum Pathol. 45:1697–1703. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mathur R, Alver BH, San Roman AK, Wilson
BG, Wang X, Agoston AT, Park PJ, Shivdasani RA and Roberts CW:
ARID1A loss impairs enhancer-mediated gene regulation and drives
colon cancer in mice. Nat Genet. 49:296–302. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang RYJ, Guilford P and Thiery JP: Early
events in cell adhesion and polarity during epithelial-mesenchymal
transition. J Cell Sci. 125:4417–4422. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gout S and Huot J: Role of cancer
microenvironment in metastasis: Focus on colon cancer. Cancer
Microenviron. 1:69–83. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xiao S, Liu L, Lu X, Long J, Zhou X and
Fang M: The prognostic significance of bromodomain PHD-finger
transcription factor in colorectal carcinoma and association with
vimentin and E-cadherin. J Cancer Res Clin Oncol. 141:1465–1474.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kolijn K, Verhoef EI and van Leenders GJ:
Morphological and immunohistochemical identification of
epithelial-to-mesenchymal transition in clinical prostate cancer.
Oncotarget. 6:24488–24498. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang X, Wang L, Zhang H, Tu F, Qiang Y
and Nie C: Decreased expression of ZO-1 is associated with tumor
metastases in liver cancer. Oncol Lett. 17:1859–1864.
2019.PubMed/NCBI
|
|
44
|
Aluksanasuwan S, Somsuan K, Wanna-Udom S,
Roytrakul S, Morchang A, Rongjumnong A and Sakulsak N: Proteomic
insights into the regulatory function of ARID1A in colon cancer
cells. Oncology Letters. 28:3922024. View Article : Google Scholar : PubMed/NCBI
|
